Wating Su

2.3k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Wating Su is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Wating Su has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Wating Su's work include Cardiac Ischemia and Reperfusion (10 papers), Autophagy in Disease and Therapy (6 papers) and Cardiovascular Function and Risk Factors (4 papers). Wating Su is often cited by papers focused on Cardiac Ischemia and Reperfusion (10 papers), Autophagy in Disease and Therapy (6 papers) and Cardiovascular Function and Risk Factors (4 papers). Wating Su collaborates with scholars based in China, Hong Kong and Macao. Wating Su's co-authors include Shaoqing Lei, Zhengyuan Xia, Yifan Jia, Danyong Liu, Liangqing Zhang, Chang Chen, Wei Mei, Fang Jiang, Jingli Chen and Zhongyuan Xia and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Biochemical Pharmacology.

In The Last Decade

Wating Su

20 papers receiving 1.6k citations

Hit Papers

Clinical characteristics and outcomes of patients undergo... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wating Su China 13 740 435 357 311 273 20 1.7k
Ken Sakai Japan 28 238 0.3× 246 0.6× 189 0.5× 559 1.8× 294 1.1× 156 2.6k
Bruno Schneeweiß Austria 33 812 1.1× 298 0.7× 106 0.3× 780 2.5× 942 3.5× 91 3.3k
Chien‐Liang Chen Taiwan 23 147 0.2× 230 0.5× 75 0.2× 232 0.7× 309 1.1× 83 1.5k
Marcin Krawczyk Germany 33 418 0.6× 474 1.1× 200 0.6× 1.1k 3.4× 520 1.9× 203 3.3k
Sang Haak Lee South Korea 28 369 0.5× 444 1.0× 135 0.4× 211 0.7× 1.2k 4.3× 195 2.4k
Youssef Bennis France 23 157 0.2× 457 1.1× 192 0.5× 167 0.5× 153 0.6× 76 1.6k
Cheng Wan China 16 286 0.4× 347 0.8× 999 2.8× 300 1.0× 132 0.5× 37 1.8k
Fabio Perrotta Italy 19 296 0.4× 159 0.4× 353 1.0× 114 0.4× 420 1.5× 81 1.4k
Diego Castanares‐Zapatero Belgium 20 84 0.1× 273 0.6× 200 0.6× 325 1.0× 354 1.3× 70 1.7k
Armin Imhof Germany 22 200 0.3× 255 0.6× 83 0.2× 382 1.2× 193 0.7× 63 2.3k

Countries citing papers authored by Wating Su

Since Specialization
Citations

This map shows the geographic impact of Wating Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wating Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wating Su more than expected).

Fields of papers citing papers by Wating Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wating Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wating Su. The network helps show where Wating Su may publish in the future.

Co-authorship network of co-authors of Wating Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wating Su. A scholar is included among the top collaborators of Wating Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wating Su. Wating Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Huilin, et al.. (2025). Caveolin-3: therapeutic target for diabetic myocardial ischemia/reperfusion injury. Molecular Medicine. 31(1). 80–80. 4 indexed citations
2.
Su, Wating, et al.. (2025). Necroptosis: a significant and promising target for intervention of cardiovascular disease. Biochemical Pharmacology. 237. 116951–116951. 2 indexed citations
3.
Su, Wating, et al.. (2024). DJ-1: Potential target for treatment of myocardial ischemia-reperfusion injury. Biomedicine & Pharmacotherapy. 179. 117383–117383. 4 indexed citations
4.
Su, Wating, Lu Zhou, Xiaojing Wu, et al.. (2023). The role of circadian clock-controlled mitochondrial dynamics in diabetic cardiomyopathy. Frontiers in Immunology. 14. 1142512–1142512. 15 indexed citations
5.
Su, Wating, et al.. (2023). FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy. Diabetes Obesity and Metabolism. 26(2). 732–744. 9 indexed citations
7.
Su, Wating, Jiabao Hou, Yafeng Wang, et al.. (2020). Sex differences in clinical characteristics and risk factors for mortality among severe patients with COVID-19: a retrospective study. Aging. 12(19). 18833–18843. 18 indexed citations
8.
Lei, Shaoqing, Fang Jiang, Wating Su, et al.. (2020). Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 21. 100331–100331. 927 indexed citations breakdown →
9.
Su, Wating, et al.. (2020). Selective Inhibition of PKCβ2 Restores Ischemic Postconditioning-Mediated Cardioprotection by Modulating Autophagy in Diabetic Rats. Journal of Diabetes Research. 2020. 1–11. 10 indexed citations
10.
Lei, Shaoqing, Wating Su, Zhongyuan Xia, et al.. (2019). Hyperglycemia-Induced Oxidative Stress Abrogates Remifentanil Preconditioning-Mediated Cardioprotection in Diabetic Rats by Impairing Caveolin-3-Modulated PI3K/Akt and JAK2/STAT3 Signaling. Oxidative Medicine and Cellular Longevity. 2019. 1–19. 53 indexed citations
12.
Zhan, Liying, Yuan Zhang, Wating Su, et al.. (2018). The Roles of Autophagy in Acute Lung Injury Induced by Myocardial Ischemia Reperfusion in Diabetic Rats. Journal of Diabetes Research. 2018. 1–9. 26 indexed citations
13.
Zhang, Yuan, Wating Su, Jinjin Xu, et al.. (2018). Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury via Inhibiting PKCβ2 Activation and Improving Mitochondrial Quality. Journal of Diabetes Research. 2018. 1–8. 19 indexed citations
14.
Qiu, Zhen, Shaoqing Lei, Bo Zhao, et al.. (2017). NLRP3 Inflammasome Activation‐Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats. Oxidative Medicine and Cellular Longevity. 2017(1). 9743280–9743280. 310 indexed citations
15.
Zhang, Yuan, Zhongyuan Xia, & Wating Su. (2016). Effects of N-acetylcysteine on oxidative stress and the expression of p22phox in lung tissue of diabetic rats. 8(3). 168–171. 1 indexed citations
16.
Su, Wating, Yuan Zhang, Jinjin Xu, et al.. (2016). N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats. Cardiovascular Diabetology. 15(1). 146–146. 49 indexed citations
17.
Zhou, Zhen, Qingtao Meng, Qian Sun, et al.. (2015). Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury following Intestinal Ischemia Reperfusion Injury in Mice. Oxidative Medicine and Cellular Longevity. 2015. 1–12. 47 indexed citations
18.
Xue, Rui, Shaoqing Lei, Zhongyuan Xia, et al.. (2015). Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways. Clinical Science. 130(5). 377–392. 72 indexed citations
19.
Sun, Qian, Qingtao Meng, Huimin Liu, et al.. (2013). Protective Effect of Ginsenoside Rb1 against Intestinal Ischemia-Reperfusion Induced Acute Renal Injury in Mice. PLoS ONE. 8(12). e80859–e80859. 49 indexed citations
20.
Lei, Shaoqing, Wating Su, Huimin Liu, et al.. (2013). Nitroglycerine-Induced Nitrate Tolerance Compromises Propofol Protection of the Endothelial Cells against TNF-α: The Role of PKC-β2and NADPH Oxidase. Oxidative Medicine and Cellular Longevity. 2013. 1–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026